MKEAY Stock Price, News & Analysis
MKEAY
OTC
Company Description
Mauna Kea Technologies (MKEAY) is a global medical device company that specializes in optical biopsy. The company's flagship product, Cellvizio, provides real-time cellular imaging during endoscopic procedures, revolutionizing the way diseases are diagnosed and monitored. Mauna Kea Technologies has established itself as a leader in the field of in vivo cellular imaging, with a strong focus on research and development to drive innovation in the medical industry.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding
Latest News
SEC Filings
No SEC filings available for MKEAY.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is Mauna Kea Technologies known for?
Mauna Kea Technologies is known for its expertise in optical biopsy and its flagship product, Cellvizio, which provides real-time cellular imaging during endoscopic procedures.
What is Cellvizio?
Cellvizio is a cutting-edge technology developed by Mauna Kea Technologies that allows for real-time cellular imaging, enabling improved diagnostic accuracy and monitoring of diseases.
What sets Mauna Kea Technologies apart in the medical device industry?
Mauna Kea Technologies stands out for its focus on in vivo cellular imaging, research, and development efforts to drive innovation in diagnosing and monitoring diseases.
How does Mauna Kea Technologies contribute to the medical field?
Mauna Kea Technologies contributes to the medical field by providing advanced optical biopsy solutions that improve diagnostic accuracy and patient outcomes, revolutionizing the way diseases are diagnosed and monitored.
What is Mauna Kea Technologies' mission?
Mauna Kea Technologies' mission is to enhance patient care by offering innovative optical biopsy solutions that enable real-time cellular imaging during endoscopic procedures, ultimately improving diagnostic accuracy and clinical outcomes.